Results 21 to 30 of about 1,529,288 (217)

Evaluation of fibrinolytic and antioxidant effects of Allium elburzense bulb extracts [PDF]

Avicenna Journal of Phytomedicine, 2017
Objective: Allium elburzense is an endemic plant of the family Amaryllidaceae that grows wild in northern Iran with some nutritional and medicinal applications.
Leila Safaeian, Behzad Zolfaghari, Mohammadreza Aghaye-Ghazvini, Mahya Behnampour   +3 more
doaj   +1 more source

Evaluation of fibrinolytic and antioxidant effects of Allium affine hydroalcoholic extract

Research in Pharmaceutical Sciences, 2017
Allium affine is a member of Amaryllidaceae family, which grows wildly in some western regions of Iran. Limited information is available about the pharmacological activities of this plant.
Masoud Sadeghi, Leila Safaeian, Mohammadreza Aghaye Ghazvini, Mojtaba Ramezani   +3 more
doaj   +1 more source

Non-sterile Submerged Fermentation of Fibrinolytic Enzyme by Marine Bacillus subtilis Harboring Antibacterial Activity With Starvation Strategy

Frontiers in Microbiology, 2019
Microbial fibrinolytic enzyme is a promising candidate for thrombolytic therapy. Non-sterile production of fibrinolytic enzyme by marine Bacillus subtilis D21-8 under submerged fermentation was realized at a mild temperature of 34°C, using a unique ...
Shihan Pan, Guiguang Chen, Rui Wu, Xiaoyan Cao, Zhiqun Liang   +4 more
doaj   +1 more source

Fibrinolytic Enzyme from Green Microalgae: A New Potential Drug for Thrombolytic Therapy?

Phycology, 2023
Thrombosis is characterized by the pathological formation of fibrin clots within a blood vessel, leading to the obstruction of blood flow. Fibrinolytic enzymes from microorganisms have been shown to be more efficient and safer in dissolving clots.
Yanara Alessandra Santana Moura, Ariadne Tennyle Vieira De Souza, Páblo Eugênio Da Costa e Silva, Marllyn Marques Da Silva, Ana Lúcia Figueiredo Porto, Raquel Pedrosa Bezerra   +5 more
doaj   +1 more source

Choice of Intrapleural Fibrinolytic Agents in the Treatment of Adult Complicated Parapneumonic Effusion and Empyema: Network Meta-Analysis

, 2023
Background: The appropriate use of intrapleural fibrinolytic agents in patients with complicated parapneumonic effusion and empyema remains unclear, especially regarding the choice of fibrinolytic agents.
Takagi, Hisato, Yokoyama, Yujiro, Burfeind, William, Kuno, Toshiki   +3 more
core   +1 more source

Food Origin Fibrinolytic Enzyme With Multiple Actions

Hayati Journal of Biosciences, 2018
Many health related problems such as cardiovascular diseases are associated with the formation of excessive clot in the blood (thrombus). Approaches in cardiovascular disease treatment are preventing the formation or removing the thrombus.
Laurentia Stephani, Raymond Rubianto Tjandrawinata, Diana Nur Afifah, Yanti Lim, Wangsa Tirta Ismaya, Maggy Thenawidjaja Suhartono   +5 more
doaj   +1 more source

Biosimilar tenecteplase versus alteplase in acute ischemic stroke: A real world study

Annals of Indian Academy of Neurology, 2023
Background and Purpose: There is an unmet need for a more effective thrombolytic agent in acute ischemic stroke (AIS) management. Various studies and meta-analysis suggest tenecteplase (TNK) as non-inferior over alteplase (rTPA).
Ayush Mohan, Snigdha Komakula, Suhas Murali, Pooja Anand, Dyuti Shah, V Y Vishnu, Awadh Kishor Pandit, Ayush Agarwal, Deepti Vibha, Mamta Bhushan Singh, M V Padma Srivastava, Rohit Bhatia   +11 more
doaj   +1 more source

Fibrinolytic therapy for parapneumonic empyema during pregnancy [PDF]

, 2012
Pneumonia and parapneumonic complicated effusion during pregnancy is uncommon but poses potentially serious risks to both mother and fetus. Enzymatic debridement of the pleural cavity with fibrinolytic agents is a noninvasive option that can facilitate ...
Ulutas, Hakki, Doru, Ihsan, Ali Sak, Zafer Hasan, Erdal Yekeler, Kuzucu, Akin, Ihsan Doru, Hakki Ulutas, Zafer Hasan Ali Sak, Akin Kuzucu, Yekeler, Erdal   +9 more
core   +1 more source

Admission Tpe interval predicts reperfusion success in STEMI patients treated with fibrinolytic agents

Türk Kardiyoloji Derneği Arşivi, 2020
Objective: Myocardial infarction is a leading cause of morbidity and mortality. Fibrinolytic administration is still a life-saving choice in ST-segment elevated myocardial infarction (STEMI), but the rate of successful reperfusion can be inconsistent ...
Ali Çoner, Sinan Akıncı, Mehmet Hüsamettin Akküçük, Cihan Altın, Haldun Müderrisoğlu   +4 more
doaj   +1 more source

Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role

Life, 2023
Blood clot formation in blood vessels (thrombosis) is a major cause of life-threatening cardiovascular diseases. These clots are formed by αA-, βB-, and ϒ-peptide chains of fibrinogen joined together by isopeptide bonds with the help of blood coagulation
Rajni Singh, Prerna Gautam, Chhavi Sharma, Alexander Osmolovskiy   +3 more
doaj   +1 more source